产品封面图
文献支持

重组鼠HAVCR2蛋白|重组鼠甲型肝炎病毒细胞受体 2蛋白

收藏
  • ¥960 - 2304
  • 卡梅德/KMD Bioscience
  • 天津
  • KMP2336
  • 2025年10月21日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.

    • 英文名

      Mouse HAVCR2 Protein, Fc Tag

    • 库存

      999

    • 供应商

      卡梅德生物科技(天津)有限公司

    • 规格

      10ug/50ug

    规格:10ug产品价格:¥960.0
    规格:50ug产品价格:¥2304.0

    产品编号:KMP2336

    产品名称:Mouse HAVCR2 Protein, Fc Tag

    中文名称: 重组鼠HAVCR2蛋白

    中文全称:重组鼠甲型肝炎病毒细胞受体2蛋白

    产品描述:产品描述:The Mouse HAVCR2 Protein(KMP2336) is produced in HEK293 Cells and the target gene encoding Arg20-Arg191 is expressed with a Fc tag at the C-terminus.

    产品别称:甲型肝炎病毒细胞受体 2, Hepatitis A virus cellular receptor 2, HAVCR2

    分子名称:HAVCR2

    预测分子量:19.13 kDa

    物种:Mouse

    宿主:HEK293 Cells

    规格:50ug, 100ug, 200ug

    纯化方式:Affinity purification

    纯度:>95% as determined by SDS-PAGE

    内毒素水平:<1.0 EU/ug determined by the LAL method

    缓冲体系:PBS, pH7.4

    Uniport:Q8VIM0

    功能:Cell surface receptor implicated in modulating innate and adaptive immune responses. Generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand (PubMed:18006747). Regulates macrophage activation (PubMed:11823861). Inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance (PubMed:14556006, PubMed:18006747). In CD8+ cells attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. The function may implicate its association with LCK proposed to impair phosphorylation of TCR subunits (By similarity). In contrast, shown to activate TCR-induced signaling in T-cells probably implicating ZAP70, LCP2, LCK and FYN (PubMed:21807895). Expressed on Treg cells can inhibit Th17 cell responses (By similarity). Receptor for LGALS9. Binding to LGALS9 is believed to result in suppression of T-cell responses; the resulting apoptosis of antigen-specific cells may implicate HAVCR2 phosphorylation and disruption of its association with BAG6 (PubMed:22863785). Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens. Expressed on Th1 cells interacts with LGALS9 expressed on macrophages to stimulate antibactericidal activity including IL-1 beta secretion and to restrict intracellular bacterial growth (PubMed:20937702). However, the function as receptor for LGALS9 has been challenged (By similarity). Also reported to enhance CD8+ T-cell responses to an acute infection such as by Listeria monocytogenes (PubMed:24567532). Receptor for phosphatidylserine (PtSer); PtSer-binding is calcium-dependent (PubMed:20083673). May recognize PtSer on apoptotic cells leading to their phagocytosis. Mediates the engulfment of apoptotic cells by dendritic cells (PubMed:19224762). Expressed on T-cells, promotes conjugation but not engulfment of apoptotic cells (PubMed:20083673). Expressed on dendritic cells (DCs) positively regulates innate immune response and in synergy with Toll-like receptors promotes secretion of TNF-alpha (PubMed:18006747). In tumor-imfiltrating DCs suppresses nucleic acid-mediated innate immune repsonse by interaction with HMGB1 and interfering with nucleic acid-sensing and trafficking of nucleid acids to endosomes (PubMed:22842346). Can enhance mast cell production of Th2 cytokines Il-4, IL-6 and IL-13 (PubMed:17620455). Expressed on natural killer (NK) cells acts as a coreceptor to enhance IFN-gamma production in response to LGALS9. In contrast, shown to suppress NK cell-mediated cytotoxicity (By similarity). Negatively regulates NK cell function in LPS-induced endotoxic shock (PubMed:25337993). Belongs to the T-cell and airway phenotype regulator (Tapr) locus, a single chromosomal region that confers reduced T-helper type 2 responsiveness and protects against airway hyperactivity (AHR), the hallmark of human asthma. In vivo administration of antibody to HAVCR2 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease and increases the number and activation level of macrophages. Endogenous expression on dendritic cells is proposed to act as a negative regulator of chemotherapy-induced antitumor responses.

    产品背景:T cell immunoglobulin and mucin domain-3(TIM3), also called hepatitis A virus cellular receptor 2(HAVCR2), is a transmembrane glycoprotein of the TIM family of immune regulating molecules and plays an important role in the Th1-mediated immune response. TIM3 is expressed on the Th1 cells, CD8 T-cells, monocytes, and dendritic cells, but not on Th2 cells. TIM3 expressed by monocytes and dendritic cells facilitates phagocytosis of apoptotic cells and up-regulates cross-presentation of apoptotic cell-associated antigens through interaction with phosphatidylserine. Engagement of TIM3 by its ligand galectin-9 induces a range of immunosuppressive functions which enhance immune tolerance and inhibit anti-tumor immunity. Stimulation of TIM3 with an agonistic antibody promotes inflammation through the activation of innate immune cells. TIM3 is also regarded as a potential target molecule for immunotherapy. TIM3 and programmed cell death 1(PD-1) as two important coinhibitory regulators of T cell responses, have been implicated with the T-cell dysfunction or exhaustion associated with chronic HBV infection including HBV-related HCC.

    保存条件:Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.

    运输条件:In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form.

    说明:This product is for research use only.

    参考文献:1.Nature 415:536-541 (2002) 2.Nat. Immunol. 4:1102-1110 (2003) 3.Blood 110:2565-2568 (2007) 4.Nat. Med. 18:1394-1400 (2012) 5.Nat. Immunol. 13:832-842 (2012) 6.J. Immunol. 184:1918-1930 (2010) 7.J. Immunol. 192:3133-3142 (2014)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    1.Nature 415:536-541 (2002) 2.Nat. Immunol. 4:1102-1110 (2003) 3.Blood 110:2565-2568 (2007) 4.Nat. Med. 18:1394-1400 (2012) 5.Nat. Immunol. 13:832-842 (2012) 6.J. Immunol. 184:1918-1930 (2010) 7.J. Immunol. 192:3133-3142 (2014)
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥960
    卡梅德生物科技(天津)有限公司
    2025年11月06日询价
    ¥1856
    上海魔兜儿生物科技有限公司
    2026年02月02日询价
    ¥800
    上海经科化学科技有限公司
    2025年07月05日询价
    ¥420
    MedChemExpress LLC
    2025年07月12日询价
    文献支持
    重组鼠HAVCR2蛋白|重组鼠甲型肝炎病毒细胞受体 2蛋白
    ¥960 - 2304